Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma
Year: 2026
Type: article
Abstract: and in the xenografted animal model. Our research provides a fundamental understanding of the therapeutic role of integrin αvβ3 and the potential therapeutic approach in cholangiocarcinoma treatment.
DOI: 10.7150/ijms.125066
Authors: Fitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, Yung-Ning Yang, Chee-Kin Then, Sachin Kumar, Fat-Moon Suk, Lin-Yi Huang, Yu-Chen SH Yang, Zi-Lin Li, Ya-Jung Shih, Hoai Tran Tu, Kuan Wang, Hoang Dang Phu, Chun-Mao Lin, Do Thi Minh Xuan, Dahlak Daniel Solomon, Hung-Yun Lin, Jacqueline Whang-Peng
Institutions: Taipei Medical University-Shuang Ho Hospital, Taipei Medical University, Albany Medical College, E-Da Hospital, I-Shou University, Shoolini University, Wan Fang Hospital, Vietnam National University Ho Chi Minh City, Ho Chi Minh City University of Science, Van Lang University, Taipei Medical University Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W7128925053